OURA SEEKS UP TO $2.2B IN IPO, ELI LILLY AND DRAGONEER SIGNAL INTEREST Oura is offering 50M shares at $40-$44 each, implying a market cap of roughly $12.8B-$14.1B. Of the 50M shares: • Oura is selling 13.5M new shares • Existing shareholders are selling 36.5M shares • Oura will not receive proceeds from the secondary shares At the $42 midpoint, Oura expects to receive about $533M in net proceeds, with roughly $526M expected to go toward tax withholding tied to RSUs vesting around the IPO. Eli Lilly has indicated interest in buying up to $100M of shares, while Dragoneer could buy up to $300M. The indications are non-binding. Lilly also already has a $50M SAFE investment that is expected to convert into roughly 1.19M Oura shares before the IPO. Oura’s business has been growing quickly: • Revenue: $1.21B for the first 9 months of FY26, +74% YoY • Net income: $60.8M vs. $1.6M a year ago • Rings sold: 3.1M vs. 1.8M • Paid members: 5.0M vs. 2.5M Oura plans to list on Nasdaq under ticker $OURA.